Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Raymond James cuts Phreesia stock price target on pharma ad headwinds
Raymond James has lowered its price target for Phreesia Inc. (NYSE:PHR) to $16 from $25, citing headwinds in pharmaceutical advertising despite the company beating Q4 fiscal 2026 revenue and adjusted EBITDA estimates. Phreesia also reduced its fiscal 2027 revenue guidance by about 7% due to lower visibility in pharma ad spending, although it maintained its adjusted EBITDA guidance by planning cost controls through AI. Other analysts, including Citizens and BMO Capital, have also adjusted their ratings and price targets following Phreesia’s updated outlook.